BurstIcon Yellow Orange Green
Provider Letter of Interest

Enthea is creating employer-sponsored benefit plan coverage for both ketamine-assisted psychotherapy (KAP) and psychedelic-assisted psychotherapy (PAP). This coverage will allow for reliable, fair and prompt reimbursement for clinical services rendered. We are offering benefit plans to employers starting with ketamine-assisted psychotherapy. MDMA-assisted psychotherapy and psilocybin-assisted psychotherapy coverage is planned for 2024.

We are currently seeking letters of interest from mental health professionals who wish to explore participating in the Enthea provider network as KAP providers now and/or PAP providers in the future (including therapists and prescribers). If you are interested in learning more, we would love to hear from you.

Please complete the following brief survey and letter of interest. This will allow for a channel of communication to keep you informed about the opportunity of network participation. Of course, your information will be kept confidential. We are a growing organization, so we sincerely appreciate your patience in advance. Thank you for sharing your time with us today.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.